HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Beth Hollister Selected Research
Beth Hollister Research Topics
Disease
6
Neoplasms (Cancer)
08/2010 - 10/2002
1
Residual Neoplasm
08/2010
1
Retinoblastoma (Glioblastoma, Retinal)
10/2005
1
Neoplasm Metastasis (Metastasis)
09/2004
1
Carcinoma (Carcinomatosis)
10/2002
1
Melanoma (Melanoma, Malignant)
10/2002
Drug/Important Bio-Agent (IBA)
3
Pharmaceutical Preparations
IBA
03/2006 - 10/2002
2
Phosphotransferases (Kinase)
IBA
02/2008 - 09/2004
1
Monoclonal Antibodies
IBA
08/2010
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
08/2010
1
Blocking Antibodies
IBA
08/2010
1
Complement System Proteins (Complement)
IBA
08/2010
1
JNJ 28871063
IBA
02/2008
1
Tyrosine (L-Tyrosine)
FDA Link
02/2008
1
Polymers
IBA
03/2006
1
IT-101
IBA
03/2006
1
Irinotecan (Camptosar)
FDA Link
Generic
03/2006
1
Camptothecin
IBA
03/2006
1
Aurora Kinases
IBA
10/2005
1
JNJ-7706621
IBA
10/2005
1
CDC2 Protein Kinase (Protein p34cdc2)
IBA
10/2005
1
Cyclin-Dependent Kinases (cdk Proteins)
IBA
10/2005
1
Member 1 Subfamily B ATP Binding Cassette Transporter
IBA
10/2005
1
Doxorubicin (Adriamycin)
FDA Link
Generic
09/2004
1
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
09/2004
1
Paclitaxel (Taxol)
FDA Link
Generic
09/2004
1
4- (4- (1- Amino- 1- methylethyl)phenyl)- 2- (4- (2- morpholin- 4- yl- ethyl)phenylamino)pyrimidine- 5- carbonitrile
IBA
09/2004
1
Angiogenesis Inhibitors
IBA
09/2004
1
Suspensions
IBA
10/2002
1
rubitecan
IBA
10/2002
Therapy/Procedure
2
Therapeutics
08/2010 - 09/2004
1
Duration of Therapy
08/2010
1
Aftercare (After-Treatment)
09/2004